- Home
- WAI vs KALA Comparison
WAI vs KALA Comparison
Compare WAI & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- KALA
- Stock Information
- Founded
- WAI 2018
- KALA 2009
- Country
- WAI China
- KALA United States
- Employees
- WAI N/A
- KALA N/A
- Industry
- WAI
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- WAI
- KALA Health Care
- Exchange
- WAI NYSE
- KALA Nasdaq
- Market Cap
- WAI 5.5M
- KALA 26.2M
- IPO Year
- WAI 2023
- KALA 2017
- Fundamental
- Price
- WAI $0.40
- KALA $7.14
- Analyst Decision
- WAI
- KALA Strong Buy
- Analyst Count
- WAI 0
- KALA 3
- Target Price
- WAI N/A
- KALA $14.00
- AVG Volume (30 Days)
- WAI 5.8M
- KALA 198.2K
- Earning Date
- WAI 08-24-2025
- KALA 08-05-2025
- Dividend Yield
- WAI N/A
- KALA N/A
- EPS Growth
- WAI N/A
- KALA N/A
- EPS
- WAI N/A
- KALA N/A
- Revenue
- WAI $3,750,352.00
- KALA N/A
- Revenue This Year
- WAI N/A
- KALA N/A
- Revenue Next Year
- WAI N/A
- KALA N/A
- P/E Ratio
- WAI N/A
- KALA N/A
- Revenue Growth
- WAI N/A
- KALA N/A
- 52 Week Low
- WAI $0.33
- KALA $2.92
- 52 Week High
- WAI $20.00
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- KALA 59.52
- Support Level
- WAI N/A
- KALA $5.35
- Resistance Level
- WAI N/A
- KALA $8.49
- Average True Range (ATR)
- WAI 0.00
- KALA 0.81
- MACD
- WAI 0.00
- KALA 0.17
- Stochastic Oscillator
- WAI 0.00
- KALA 57.01
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.